Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatment
Conclusion:
We propose that a good therapeutic response to FTY might be predisposing for a severe rebound after withdrawal. Consequently, therapy switches should be planned carefully with a short therapy free interval.
Source: Therapeutic Advances in Neurological Disorders - Category: Neurology Authors: Faissner, S., Hoepner, R., Lukas, C., Chan, A., Gold, R., Ellrichmann, G. Tags: Reviews Source Type: research